Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.
作者： M. Niedrig , M. Lademann , P. Emmerich , M. Lafrenz
DOI: 10.1046/J.1365-3156.1999.00496.X
关键词: Vaccination 、 Antibody 、 Yellow fever 、 Serology 、 Virology 、 Virus 、 Biology 、 Titer 、 Yellow fever vaccine 、 Immunofluorescence
摘要: We analysed serum samples of 209 subjects immunized with yellow fever vaccine 17D by different assays: neutralization test, immunofluorescence assay, haemagglutination inhibition test and ELISA, for presence 17D-specific antibodies. Serum were taken from a few weeks up to 35 years after vaccination. The had the highest sensitivity. There was no correlation results between serological assays. Considering NT titres > 1:10 as indicating protection, we found that about 75% remained immune even 10 vaccination, median titre 1:40 in reactive sera.
sci-hub.se 参考文章(15)
J S Porterfield, A T De Madrid, A simple micro-culture method for the study of group B arboviruses. Bulletin of The World Health Organization. ,vol. 40, pp. 113- 121 ,(1969)
H. G. Schatzmayr, C. F. T. Yoshida, E. Lampe, M. A. Travassos-Da-Rosa, C. D. Rouzere, B. O. M. Vanderborght, R. M. R. Nogueira, Human antibodies to dengue and yellow fever do not react in diagnostic assays for hepatitis C virus. Brazilian Journal of Medical and Biological Research. ,vol. 25, pp. 1131- 1135 ,(1992)
Groot H, Riberiro Rb, Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine. Bulletin of The World Health Organization. ,vol. 27, pp. 699- 707 ,(1962)
Edwin H. Lennette, David A. Lennette, Evelyne T. Lennette, Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections ,(1989)
T P Monath, K Murphy, W G Downs, J D Poland, C H Calisher, Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine Bulletin of The World Health Organization. ,vol. 59, pp. 895- 900 ,(1981)
Max Theiler, Hugh H. Smith, THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION Journal of Experimental Medicine. ,vol. 65, pp. 787- 800 ,(1937) , 10.1084/JEM.65.6.787
Barbara Reinhardt, Robert Jaspert, Matthias Niedrig, Christian Kostner, Johanna L'age-Stehr, Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection Journal of Medical Virology. ,vol. 56, pp. 159- 167 ,(1998) , 10.1002/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B
S Oehen, H Waldner, T M Kündig, H Hengartner, R M Zinkernagel, Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. Journal of Experimental Medicine. ,vol. 176, pp. 1273- 1281 ,(1992) , 10.1084/JEM.176.5.1273
D Gray, P Matzinger, T cell memory is short-lived in the absence of antigen Journal of Experimental Medicine. ,vol. 174, pp. 969- 974 ,(1991) , 10.1084/JEM.174.5.969
K. C. Smithburn, A. F. Mahaffy, Immunization against Yellow Fever. Studies on the Time of Development and the Duration of Induced Immunity. American Journal of Tropical Medicine and Hygiene. ,vol. 25, pp. 217- 223 ,(1945) , 10.4269/AJTMH.1945.S1-25.217